New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (‘Blue Mystic’)

Abstract

2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first synthesized in 1986; its desired effects include both a sense of empathy and of well-being. Hallucinations, nausea, anxiety, panic attacks and paranoid ideation are anecdotally reported. According to the different European sources here approached, the availability of 2C-T-7 at street level seems to be currently very low, although one death related to a mono-intoxication with 2C-T-7 has been documented in the USA. With respect to information on 2C-T-7 available online, due to both redundancy and relevance issues the initial identified sample of 360 was reduced to 118 websites. In 14 (11.9%) websites, the detailed description of the 2C-T-7 synthesis was given. Harm Reduction websites appeared significantly earlier in the search engines results’ list than Anti drugs (p 0.006) websites. Five (4.2%) websites apparently offered 2C-T-7 for sale. The large body of knowledge available online seems to contrast with small numbers of seizures at street level; an exhaustive web mapping of drug-related issues may be of interest for the clinician. Projects aimed at designing more ‘attractive’ prevention websites should be planned and future studies should better assess the characteristics of those consumers who take advantage of the online information of hallucinogenic compounds.

Keywords

2C-T-7 phenethylamines hallucinogens MDMA ecstasy drug abuse Internet online sales drug abuse prevention designer drugs

Get full access to this article

View all access options for this article.

References

Aghajanian G K , Marek G J (1999) Serotonin and hallucinogens. Neuropsychopharmacol 21 (Suppl. 2): 16S-23S

Backstrom J R , Chang M S , Chu H , Niswender C M , Sanders-Bush E (1999) Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD). Neuropsychopharmacol 21(Suppl. 2): 77S-81S

Balestrieri A , Fontanari D (1959) Acquired and cross tolerance to mescaline, LSD-25, and BOL-148. Arch Gen Psychiatry 1: 279-282

Curtis B , Harty L , Kemp P , Choi C , Sneed G , Christensen D (2001) Preliminary investigation into identification and quantitation of 2,5-dimethoxy-n-propylthiophenethylamine a.k.a. 2C-T-7. Proceedings of the Fall meeting, Southwestern Association of Toxicologists, San Antonio. Available at: http://www.sat-tox.org/sanantonio.html. Accessed on 16 August 2004

Curtis B , Kemp P , Harty L , Choi C , Christensen D (2003) Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propylthiophenethylamine using GC-MSD and GC-NPD. J Anal Toxicol 27: 493-498

De Boer D , Bosman I (2004) A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs. Pharm World Sci 26: 110-113

Drug Enforcement Administration (2004) DEA announces arrests of website operators selling illegal designer drugs. Available at: http://www.dea.gov/pubs/pressrel/pr072204.html. Accessed on 19 August 2004

European Monitoring Centre for Drugs and Drug Addiction (2004) Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. Office for Official Publications of the European Communities, Luxembourg

Falck R S , Carlson R G , Wang J , Siegal H A (2004) Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users. Drug Alcohol Depend 74: 45-54

10.

Gewirtz J C , Marek G J (2000) Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacol 23: 569-576

11.

Glennon R A (1990) Do classical hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacol 3: 509-517

12.

Hardison C (2000) An amateur qualitative study of 48 2C-T-7 subjective bioassays. MAPS Bulletin 10: 11

13.

Khorana N , Pullagurla M R , Dukat M , Young R , Glennon R A (2004) Stimulus effects of three sulfur-containing psychoactive agents. Pharmacol Biochem Behav 78: 821-826

14.

Littlejohn C , Baldacchino A , Schifano F , Deluca P (2005) Internet pharmacies and online prescription drug sales: a cross-sectional study. Drug Educ Prev Policy 12: 75-80

15.

Marek G J , Aghajanian G K (1996) LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther 278: 1373-1382

16.

Murple (2001) Sulphurous Samadhi: An Investigation of 2C-T-2 and 2C-T-7. Available at: http://www.erowid.org/chemicals/2ct7/article1/article1.shtml. Accessed on 6 May 2004

17.

Peyton III J , Shulgin A T (1994) Structure-activity relationships of the classic hallucinogens and their analogs. In: Lin G C , Glennon R A (eds), Hallucinogens: An Update. NIDA Research Monograph 146, National Institute on Drug Abuse, Rockville, MD, pp. 74-91

18.

Riva G (2001) From real to virtual communities: cognition, knowledge and intention in the World Wide Web. In: Wolfe C R (ed.), Learning and Teaching on the World Wide Web. Academic Press, San Diego, CA

19.

Sanders-Bush E , Burris K D , Knoth K (1988) Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther 246: 924-928

20.

Schifano F , Leoni M , Martinotti G , Rawaf S , Rovetto F (2003) Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 Project. Cyber Psychol Behav 6: 405-410

21.

Stolaroff M J , Wells C W (1993) Preliminary Results with New Psychoactive Agents 2C-T-2 and 2C-T-7. Yearbook Ethnomed, pp. 99-117

22.

Titeler M , Lyon R A , Glennon R A (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacol (Berl) 94: 213-216

23.

Totse (2004) Available at: http://www.totse.com/en/drugs/psychedelics/164969.html. Accessed on 6 May 2004

24.

Vollenweider F X (1998) Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiat 31 (Suppl. 2): 92-103

25.

Vorce S P , Sklerov J H (2004) A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. Anal Toxicol 28: 407-410

26.

Wax P (2002) Just a click away: recreational drug web sites on the Internet. Pediatr 109: 96-100